PNC Financial Services Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

PNC Financial Services Group’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-180	Closed	-$706	–	4837
2023 Q3	$706	Buy	+180	New	+$1.23K	﹤0.01%	4428

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PNC Financial Services Group's EVLO Position: Q4 2023 in Review

PNC Financial Services Group sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 180 shares — an estimated $706 sold.

PNC Financial Services Group first reported a position in EVLO in Q3 2023 and held it in 1 quarter. The position peaked at $706 in Q3 2023. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

PNC Financial Services Group reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
PNC Financial Services Group sold 180 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $706.
PNC Financial Services Group first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
PNC Financial Services Group's Evelo Biosciences, Inc. Common Stock position peaked at $706 in Q3 2023.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on PNC Financial Services Group's 13F filing for Q4 2023, filed 9 Feb 2024.